Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
NCI, INC. Issues Q3 2012 Guidance In Line With Analysts' Estimates; Raises FY 2012 EPS Guidance; Narrows FY 2012 Revenue Guidance To A Range In Line With Analysts' Estimates
NCI, INC. announced that for third quarter of 2012, it expects revenue to be in a range of $82-$88 million and diluted earnings per share (EPS) in a range of $0.06-$0.09. For fiscal 2012, it expects revenue to be in a range of $352-$368 million and diluted EPS in a range of $0.33-$0.40. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of 85 million and EPS of $0.06 for third quarter of 2012; revenue of $356 million and EPS of $0.30 for fiscal 2012.
Latest Developments for NCI Inc
- NCI Inc Issues Q2 2013 Guidance; EPS Guidance Above Analysts' Estimates; Raises Low End Of Prior FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance
- NCI Inc Issues Q1 2013 Guidance In Line With Analysts' Estimates; Issues FY 2013 Guidance; EPS Guidance Below Analysts' Estimates
- NCI Inc Expects To Meet Or Exceed FY 2012 Guidance
- NCI Inc Issues Q4 2012 Guidance; EPS Guidance Above Analysts' Estimates; Raises FY 2012 Guidance
- Share this
- Link this
- Digg this
Follow Reuters